BIOLOGICAL INDICATORS IN HEART INFECTIONS: DYNAMICS OF BIOMARKERS IN INFECTIOUS ENDOCARDITIS.
Keywords:
invaziyaAbstract
This article is about infectious endocarditis (IE), a disease of infectious nature, primarily focusing on the pathophysiological changes occurring in the heart valves and pericardial endocarditis, as well as the clinical analysis of the disease. Foci of infection are identified in the myocardium, and complications are observed in blood platelets, manifesting as a general response and high mortality rate. Several factors play a significant role in the development of this disease, including heart diseases, infections, and drug addiction. Modern biomarkers are used for the diagnosis and treatment of infectious endocarditis.
References
1. Дорофейков ВВ. ST2 – новый маркер сердечной недостаточности и прогноза пациентов с сердечно-сосудистыми заболеваниями // Лаборатория. – 2014. - N 4. – P. 18–22.
2. Костюченко А. Л., Иммунный ответ организма на хирургическую инфекцию./ В кн.: Хирургические инфекции: руководство./ Под ред. И. А. Ерюхина, Б. Р. Гельфанда, С. А. Шляпникова. — СПб.: Питер, 2003. — С. 114— 130.
3. Ковалев С.А., Воронцова З.А., Грязнов Д.В., Лавренов А.Л., Золотарева С.Н., Добросоцких Г.В., Тесленко О.И., Андриенко О.Е., Зверев Р.В., Ахмадзай Р.Л. Сравнение предоперационных иммунологических показателей у пациентов, оперированных по поводу различных форм инфекционного эндокардита. // Вестник новых медицинских технологий. Электронное издание. 2017. – N 2. DOI: 10.12737/article_593f9adf70f7c1.32503082
4. Bannay A., Hoen B., Duval X., Obadia J.F., Selton-Suty C. et al. The impact of valve surgery on short- and long-term mortality in leftsided infective endocarditis: do differences in methodological approaches explain previous conflicting results? // Eur. Heart. J. - 2011. - Vol. 32. – P. 2003-2015.
5. Ciccone M.M., Cortese F., Gesualdo M., Riccardi R., Di Nunzio D., Moncelli M., Iacoviello M., Scicchitano P. A Novel Cardiac Bio-Marker: ST2: A Review. // Molecules. – 2013. – Vol. 18. – P. 15314–28.
6. deFilippi C.R., de Lemos J.A., Christenson R.H., Gottdiener J.S., Kop W.J., Zhan M., Seliger S.L. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. // JAMA. – 2010. – Vol. 304. – P. 2494 –2502.
7. Dayer M.J., Jones S., Prendergast B., Baddour L.M., Lockhart P.B., Thornhill M.H. Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis. // Lancet. – 2015. – Vol. 385. – P. 1219–28.
8. Domingo A. Pascual-Figal, Jordi Ordoñez-Llanos et al. Soluble ST2 for Predicting Sudden Cardiac Death in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction. // J. Am. Coll. Cardiol. – 2009. – Vol. 54. – P. 2174–79.
9. Harinstein M.E., Marroquin O.C. External coronary artery compression due to prosthetic valve bacterial endocarditis. // Catheter Cardiovasc. Interv. – 2014. – Vol. 83. – P. 168–70.
10. Ho J.E., Chen W.Y., Chen M.H., Larson M. G., McCabe E.L., Cheng S., Ghorbani A., Coglianese E., Emilsson V., Johnson A.D., Walter S., Franceschini N., O’Donnell C.J. Common genetic variation at the IL1 RL1 locus regulates IL-33/ST2 signaling. // J. Clin. Invest. – 2013. Vol. 123. – P. 4208–18.
11. Murdoch D.R., Corey G.R., Hoen B., et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective ohort Study. // Arch. Intern. Med. – 2009. - Vol. 169. – P. 463-73.
12. Maruna P., Nedelnikova K., Gurlich R. Physiology and genetics of procalcitonin. // Physiol. Research. – 2000. – Vol. 49 (Suppl 1). – P. 57–61.
13. Pascual-Figal D.A., Januzzi J. L. The biology of ST2: The International ST2 Consensus // Panel. Am. J. Cardiol. 2015. – Vol. 115. – P. 3–7.
14. Que Y.A., Moreillon P. Infective endocarditis // Nat. Rev. Cardiol. – 2011. – Vol. 8. – P. 322-36.
15. Qu J., Lu X., Liu Y., Wang X. Evaluation of procalcitonin, C-reactive protein, interleukin-6 & serum amyloid A as diagnostic biomarkers of bacterial infection in febrile patients. // Indian. J. Med. Res. – 2015. – Vol. 141. – P. 315-21.
16. Spaulding A.R., Lin Y.-C., Merriman J.A., Brosnahan A.J., Peterson M.L., Schlievert P.M. Immunity to Staphylococcus aureus Secreted Proteins Protects Rabbits from Serious Illnesses. // Vaccine. - 2012. – Vol. 30. – P. 5099–109.
17. Stancoven A. B., Shiue A. B., Khera A., Pinkston K., Hashim .A., Wang A., de Lemos J.A., Peterson G.E. Association of Troponin T, Detected With Highly Sensitive Assay, and Outcomes in Infective Endocarditis. // Am. J. Cardiol. – 2011. – Vol. 108. – P. 416–20.
18. Willems S., Hoefer I., Pasterkamp G. The role of the interleukin 1 receptor-like 1 (ST2) and Interleukin-33 pathway incardiovascular disease and cardiovascular risk assessment. // Minerva Med. – 2012. – Vol. 103. – P. 513-24.
19. Weinberg E. O. ST2 protein in heart disease: From discovery to mechanisms and prognostic value. // Biomark. Med. – 2009. – Vol. 3. – P. 495–511.
20. Yaegashi Y., Shirakawa K., Sato N. et al. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. // Journal of Infection and Chemotherapy. – 2005. – Vol. 11. – P. 234-38.
21. Zencir C., Akpek M., Senol S., Selvi M., Onay S., Cetin M., et al. Association between hematologic parameters and inhospital mortality among patients with infective endocarditis // Kaohsiung J. Med. Sci. – 2015. – Vol. 31. – P. 632-8.